HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Futoshi Kuribayashi Selected Research

Urinary Bladder Neoplasms (Bladder Cancer)

12/2022Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Futoshi Kuribayashi Research Topics

Disease

6Neoplasms (Cancer)
01/2024 - 01/2019
4Infections
04/2023 - 03/2011
3Neoplasm Metastasis (Metastasis)
12/2022 - 09/2022
3Leukemia
11/2020 - 04/2010
2Chronic Granulomatous Disease
04/2023 - 06/2011
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 01/2017
2Inflammation (Inflammations)
11/2022 - 02/2014
1Triple Negative Breast Neoplasms
01/2024
1Fatigue
01/2024
1Inborn Genetic Diseases (Disease, Hereditary)
04/2023
1Breast Neoplasms (Breast Cancer)
01/2023
1Urinary Bladder Neoplasms (Bladder Cancer)
12/2022
1Melanoma (Melanoma, Malignant)
09/2022
1Lung Neoplasms (Lung Cancer)
09/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1COVID-19
01/2022
1Hypoxia (Hypoxemia)
10/2021
1Hemangioendothelioma
10/2021
1Alzheimer Disease (Alzheimer's Disease)
03/2021
1Obesity
03/2021
1Cardiovascular Diseases (Cardiovascular Disease)
03/2021
1Diabetes Mellitus
03/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Non-alcoholic Fatty Liver Disease
01/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2015
1Xeroderma Pigmentosum (Kaposi's Disease)
11/2012
1Communicable Diseases (Infectious Diseases)
06/2011
1Pulmonary Alveolar Proteinosis
03/2011
1T-Cell Lymphoma (Lymphoma, T Cell)
02/2011

Drug/Important Bio-Agent (IBA)

4Superoxides (Superoxide)IBA
04/2023 - 03/2011
2Annexin A2 (Annexin II)IBA
01/2024 - 01/2023
2Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2024 - 01/2023
2NADPH Oxidases (NAD(P)H oxidase)IBA
04/2023 - 10/2021
2CollagenIBA
01/2023 - 01/2017
2Proteins (Proteins, Gene)FDA Link
09/2022 - 10/2021
2PhytochemicalsIBA
03/2021 - 01/2018
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2018 - 04/2010
1linaloolIBA
01/2024
1AntioxidantsIBA
01/2024
1CytokinesIBA
01/2024
1Dopamine (Intropin)FDA LinkGeneric
01/2024
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2024
1InterleukinsIBA
01/2024
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2024
1Oxygen (Dioxygen)IBA
01/2024
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024
1NADPH Oxidase 2IBA
04/2023
1IntegrinsIBA
01/2023
1Biomarkers (Surrogate Marker)IBA
12/2022
1Toll-Like Receptor 4IBA
12/2022
1pyrazoleIBA
11/2022
1RNA (Ribonucleic Acid)IBA
11/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2022
1histidine-rich proteinsIBA
09/2022
1Chemotactic FactorsIBA
09/2022
1Blood Proteins (Serum Proteins)IBA
09/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2021
1NADPH Oxidase 4IBA
10/2021
1Messenger RNA (mRNA)IBA
10/2021
1CX 5461IBA
11/2020
1RNA Polymerase I (Polymerase I, RNA)IBA
11/2020
1Glycoproteins (Glycoprotein)IBA
01/2019
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2019
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2019
1ResveratrolIBA
01/2018
1StilbenesIBA
01/2018
1lysophosphatidic acidIBA
01/2017
1matrigelIBA
01/2017
1Protein Isoforms (Isoforms)IBA
07/2015
1Cytidine DeaminaseIBA
07/2015
1LipidsIBA
02/2014
1Peptides (Polypeptides)IBA
02/2014
1ChemokinesIBA
02/2014
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
11/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2011
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2011
1Syk KinaseIBA
02/2011
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2011
1Agammaglobulinaemia Tyrosine KinaseIBA
02/2011
1PolyphenolsIBA
04/2010
1CurcuminIBA
04/2010
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
04/2010

Therapy/Procedure

1Oral Administration
01/2022
1Drug Therapy (Chemotherapy)
11/2020
1Therapeutics
04/2010